Amphastar (AMPH) director awarded 7,886 RSUs and 16,646 options at $19.02
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Pierce Anthony T reported acquisition or exercise transactions in this Form 4 filing.
Amphastar Pharmaceuticals director Anthony T. Pierce received equity compensation on July 9, 2026, consisting of 7,886 restricted stock units and 16,646 stock options. All RSUs and options vest on July 9, 2027, with the options exercisable at $19.02 per share and expiring on July 9, 2036. These are grants, not open‑market purchases or sales.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Pierce Anthony T
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 16,646 | $0.00 | -- |
| Grant/Award | Common Stock | 7,886 | $0.00 | -- |
Holdings After Transaction:
Stock Option (right to buy) — 16,646 shares (Direct);
Common Stock — 7,886 shares (Direct)
Footnotes (1)
- The reported shares are represented by restricted stock units, or RSUs, all of which vest on July 9, 2027. All of the shares subject to the option vest on July 9, 2027.
Key Figures
RSU grant: 7,886 shares
Stock options granted: 16,646 options
Option exercise price: $19.02 per share
+3 more
6 metrics
RSU grant
7,886 shares
Restricted stock units granted to Anthony T. Pierce on July 9, 2026
Stock options granted
16,646 options
Stock Option (right to buy) granted to Pierce on July 9, 2026
Option exercise price
$19.02 per share
Conversion or exercise price of granted stock options
RSU vesting date
July 9, 2027
All reported RSUs vest on this date
Option vesting date
July 9, 2027
All shares subject to the option vest on this date
Option expiration
July 9, 2036
Expiration date of the granted stock options
Key Terms
restricted stock units, Stock Option (right to buy), vest, exercise price
4 terms
restricted stock units financial
"The reported shares are represented by restricted stock units, or RSUs, all of which vest"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Stock Option (right to buy) financial
"Stock Option (right to buy) with an exercise price of 19.0200 and expiration date"
vest financial
"All of the shares subject to the option vest on July 9, 2027"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
exercise price financial
"conversion_or_exercise_price of 19.0200 for the stock option grant"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
What equity awards did Amphastar (AMPH) director Anthony T. Pierce receive?
Anthony T. Pierce received 7,886 restricted stock units and 16,646 stock options in Amphastar Pharmaceuticals. Both awards were granted as equity compensation on July 9, 2026, and represent additional potential ownership if vesting conditions are satisfied and options are exercised.
When do Anthony T. Pierce’s new Amphastar (AMPH) RSUs and options vest?
All of Anthony T. Pierce’s newly granted Amphastar equity awards vest on July 9, 2027. This single vesting date applies both to the 7,886 restricted stock units and the 16,646 stock options, meaning they become fully earned on that date if conditions are met.
What is the exercise price and term of Anthony T. Pierce’s Amphastar (AMPH) stock options?
Pierce’s newly granted Amphastar stock options cover 16,646 shares at an exercise price of $19.02 per share. These options expire on July 9, 2036, giving a ten‑year term from the grant date, with vesting scheduled for July 9, 2027.